Expanding Targeted Delivery Beyond the Liver: Harnessing Peptides to Unlock the Next Generation of Oligonucleotide Therapeutics
1:30 pm - Wednesday 2nd December 2026
- Explore how peptide-based delivery technologies are enabling targeted delivery of antisense oligonucleotides (ASOs) to extrahepatic tissues, including the lung and oncology indications.
- Discover strategies for overcoming tissue-specific delivery barriers to improve cellular uptake, therapeutic efficacy, and target engagement.
- Examine case studies demonstrating how peptide conjugates are expanding the clinical potential of oligonucleotide therapeutics across previously inaccessible disease areas.
